Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease (Di martedì 2 luglio 2024)
SHANGHAI, July 2, 2024 /PRNewswire/
Pulnovo Medical Limited, a Globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and First two patients Enrollment for its Global multicenter Clinical Study exploring the percutaneous Pulmonary artery denervation (PADN) treatment for Pulmonary Hypertension Associated with Left Heart Disease. This landmark event took place at Centro Hospitalar Universitário de Lisboa Central - Hospital de Santa Marta in Portugal, marking the beginning of Pulnovo Medical's innovative product deployment on a Global scale. Under the guidance of Professor Hang Zhang from Nanjing Medical University Affiliated Nanjing Hospital, Prof.Leggi tutta la notizia su liberoquotidiano
Notizie su altre fonti
Pulnovo Medical Limited, a Globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and First two patients Enrollment for its Global multicenter Clinical Study exploring the percutaneous Pulmonary artery denervation (PADN) treatment for Pulmonary Hypertension Associated with Left Heart Disease. This landmark event took place at Centro Hospitalar Universitário de Lisboa Central - Hospital de Santa Marta in Portugal, marking the beginning of Pulnovo Medical's innovative product deployment on a Global scale. Under the guidance of Professor Hang Zhang from Nanjing Medical University Affiliated Nanjing Hospital, Prof.Leggi tutta la notizia su liberoquotidiano
- Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease - pulnovo medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two ... msn
- PODD Drug Delivery Conference Announces 2024 Keynotes and Agenda - The Conference Forum announces the keynotes and plenary sessions for the 14th annual PODD: Partnership Opportunities in Drug Delivery conference, which will take place on October 28-29 at the Westin ... lelezard
- SILICON VALLEY INNOVATIONS, INC APPOINTS MEDTECH VETERAN HOWARD PALEFSKY TO BOARD OF DIRECTORS - pulnovo medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease pulnovo medical Limited, a ... lelezard
Video Pulnovo Medical
Video Pulnovo Medical
Facebook
Tik Tok
Twitter
Instagram
You Tube
Iscriviti
